Daily Anesthesiology Research Analysis
Analyzed 79 papers and selected 3 impactful papers.
Summary
Three impactful studies in anesthesiology and perioperative care stood out today: a population-level cohort revealed informative missingness of 5‑min Apgar scores that biases out-of-hospital birth safety estimates; an updated, GRADE-based Perioperative Resuscitation and Life Support (PeRLS) guideline provides actionable algorithms for perioperative cardiac arrest; and a meta-analysis supports neurofilament light chain as a biomarker candidate for postoperative delirium.
Research Themes
- Bias and data integrity in perinatal outcomes
- Perioperative resuscitation guideline algorithms
- Biomarkers for postoperative delirium risk stratification
Selected Articles
1. Selective nonreporting of 5-min Apgar scores and its safety assessment of out-of-hospital births: a population-based study of United States' birth data, 2016-2023 a population based study.
Using over 3 million US births, the authors show that 5-minute Apgar scores are disproportionately missing in out-of-hospital settings. Deterministic sensitivity analyses indicate that even modest assumptions about missing low scores markedly increase the estimated risk of severe compromise for home and birth-center deliveries versus hospitals.
Impact: This study exposes a critical documentation bias that can mislead safety assessments of out-of-hospital births, directly impacting patient counseling and health policy.
Clinical Implications: Counseling for out-of-hospital birth should incorporate the likelihood of informative missingness in Apgar scores. Regulators and institutions should mandate complete, auditable outcome reporting to enable valid safety comparisons.
Key Findings
- 5-minute Apgar score missingness: 0.13% (hospital), 1.9% (birth center), 3.1% (home).
- Observed severe compromise (Apgar <4): 0.17% (hospital), 0.20% (birth center), 0.26% (home).
- Assuming 50% of missing scores are <4, adjusted odds of severe compromise rose to 7.7 (home) and 4.9 (birth center) versus hospitals.
Methodological Strengths
- Nationwide, population-based cohort of 3,066,021 term, normal-birthweight, midwife-attended singleton births.
- Deterministic sensitivity analyses explicitly modelled informative missingness.
Limitations
- Observational registry data are susceptible to residual confounding and coding errors.
- Sensitivity analyses rely on assumptions about the distribution of missing scores.
Future Directions: Implement mandatory standardized outcome reporting and prospectively validate unbiased safety comparisons across birth settings, including linkage with neonatal outcomes.
BACKGROUND: The safety of out-of-hospital birth in the United States remains contested. A neglected methodological issue is the selective nonreporting of 5-min Apgar scores, which may conceal adverse outcomes and bias safety comparisons. This study examined whether Apgar score missingness differs systematically by birth setting and whether such "informative missingness" alters risk estimates. METHODS: We conducted a population-based analysis of 3,066,021 term, normal-birthweight, midwife-attended singleton births in the United States (2016-2023). Birth settings included hospitals, freestanding birth centers, and planned home births. Missing 5-min Apgar scores were quantified, and deterministic sensitivity analyses modeled the impact of varying assumptions about unrecorded low scores (<4 and <7). Hospital births served as the reference group. FINDINGS: Five-minute Apgar scores were missing in 0.13% of hospital, 1.9% of birth-center, and 3.1% of home births. Severe compromise (Apgar <4) occurred in 0.17%, 0.20%, and 0.26%, respectively. When half of missing scores were imputed as <4, adjusted odds of severe compromise increased to 7.7 for home and 4.9 for birth-center births vs. hospitals. INTERPRETATION: This study evaluates documentation integrity of US births. Selective nonreporting of 5-min Apgar scores at out-of-hospital births introduces major bias, distorting apparent safety of out-of-hospital births. Complete and enforceable outcome reporting is essential for scientific validity and ethically sound informed consent. FUNDING: None declared.
2. Perioperative Resuscitation and Life Support (PeRLS): An Update.
This PeRLS update leverages GRADE methodology to synthesize current evidence and provide structured recommendations and algorithms tailored to perioperative cardiac arrest, emphasizing rapid etiologic diagnosis and targeted resuscitation. It extends applicability beyond the OR to ICU and ED settings.
Impact: Provides an updated, evidence-graded framework for perioperative arrest management where witness rates and known precipitants enable cause-directed resuscitation.
Clinical Implications: Adopting PeRLS algorithms can standardize rapid assessment, prioritize reversible causes (e.g., hemorrhage, embolism, anesthetic complications), and harmonize ICU/ED practices with perioperative resuscitation strategies.
Key Findings
- Perioperative arrests are typically witnessed with identifiable triggers, enabling targeted, timely treatment.
- The update uses GRADE to appraise evidence and formulate recommendations and algorithms for perioperative arrest prevention and management.
- Recommendations are applicable beyond the OR, including ICU and emergency department contexts.
Methodological Strengths
- GRADE methodology for transparent evidence appraisal and recommendation strength.
- Multidisciplinary authorship and focus on actionable algorithms.
Limitations
- Guideline recommendations may rely on heterogeneous and limited-quality evidence across topics.
- Lack of randomized prospective validation of algorithms in diverse settings.
Future Directions: Prospective, multicenter evaluations of algorithm adherence and outcomes; integration of real-time monitoring and decision support to operationalize cause-directed resuscitation.
Cardiovascular collapse and arrest in the periprocedural setting and intensive care unit differ from arrests in other contexts (such as out-of-hospital or hospital ward) because clinicians almost always witness the event, and the most likely precipitating cause may be known. In comparison to other settings, the response can be timelier and more focused on treating the underlying cause(s). Since many patients deteriorate over minutes to hours, clinicians can evaluate the patient expeditiously, generate a diagnosis, and initiate appropriate treatment more rapidly than in other arrest circumstances. This iteration of Perioperative Resuscitation and Life Support (PeRLS) employs Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) methodology to review the most recent evidence on preventing and managing cardiac arrest during the perioperative period. Furthermore, many of the recommendations and algorithms may also be applicable to areas outside the operating room, such as the intensive care unit and emergency room.
3. Neurofilament light chain as a potential biomarker of perioperative neurocognitive disorders: a systematic review and meta-analysis.
Across observational studies, both preoperative and postoperative NfL levels are higher in patients who develop postoperative delirium, and blood NfL increases after surgery irrespective of delirium. These findings support NfL as a candidate biomarker for POD and motivate studies defining thresholds and timing.
Impact: Identifies a scalable blood-based biomarker candidate for POD, enabling preoperative risk stratification and perioperative monitoring strategies.
Clinical Implications: Preoperative and early postoperative NfL measurement could inform delirium-prevention bundles and targeted monitoring in high-risk patients; implementation will require assay standardization and validated cutoffs.
Key Findings
- Postoperative blood NfL increases within groups for both POD (SMD 0.49) and no-POD (SMD 0.67) patients.
- Preoperative CSF NfL is higher in patients who develop POD (SMD 0.27).
- Both preoperative and postoperative blood NfL are higher in POD versus non-POD (SMD 0.53 and 0.58).
Methodological Strengths
- PRISMA-guided systematic review with PROSPERO registration (CRD42024516907).
- Risk of bias assessed via Newcastle–Ottawa Scale; quantitative synthesis with STATA.
Limitations
- Heterogeneity in assays, timing, and PND phenotyping across studies.
- Predominantly observational evidence; clinical cutoffs and added predictive value remain undefined.
Future Directions: Prospective validation of NfL thresholds and trajectories for POD prediction, integration into multimodal risk models, and assessment of NfL-guided prevention strategies.
OBJECTIVES: Although neurofilament light chain (NfL) is used as a biomarker of neurodegenerative decline, its application in surgery- and anaesthesia-induced acute cognitive dysfunction remains uncertain. We aimed to synthesise existing evidence to evaluate the potential of NfL as a biomarker for perioperative neurocognitive disorder (PND). DESIGN: Systematic review and meta-analysis. DATA SOURCES: PubMed, EMBASE, MEDLINE, the Cochrane Library and the Cochrane Central Register of Clinical Trials were systematically searched up to March 2024. ELIGIBILITY CRITERIA: Observational studies-including cohort, case-control and cross-sectional designs-were included if they reported cerebrospinal fluid (CSF) or blood NfL levels in individuals with and without PND. DATA EXTRACTION AND SYNTHESIS: Three independent reviewers assessed each article. Quality scoring was conducted, and the extracted data were analysed using STATA. Risk of bias was evaluated using the Newcastle-Ottawa Scale. Meta-analytical model selection was guided by the I RESULTS: Within-group analyses showed significant postoperative increases in blood NfL levels in both the postoperative delirium (POD) group (standardised mean difference (SMD) = 0.49; 95% CI 0.34 to 0.64) and the no-POD group (SMD=0.67, 95% CI 0.53 to 0.81). Between-group comparisons revealed significantly higher preoperative CSF NfL levels in the POD group (SMD=0.27, 95% CI 0.07 to 0.47). Both preoperative and postoperative blood NfL levels were also significantly elevated in the POD group (SMD=0.53, 95% CI 0.40 to 0.66, and SMD=0.58, 95% CI 0.43 to 0.73, respectively). CONCLUSIONS: This meta-analysis suggests that NfL may be a potential biomarker for POD. Further research is needed to clarify the association between CSF and blood NfL levels and other forms of PND. PROSPERO REGISTRATION NUMBER: CRD42024516907.